StockNews.com cut shares of DaVita (NYSE:DVA – Free Report) from a buy rating to a hold rating in a report issued on Friday morning.
Several other analysts have also recently issued reports on the company. Barclays increased their price objective on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $166.33.
Check Out Our Latest Stock Analysis on DVA
DaVita Trading Down 0.5 %
DaVita (NYSE:DVA – Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, equities analysts expect that DaVita will post 10.76 earnings per share for the current year.
Hedge Funds Weigh In On DaVita
Several hedge funds have recently made changes to their positions in DVA. Copia Wealth Management purchased a new position in shares of DaVita during the fourth quarter worth about $30,000. SBI Securities Co. Ltd. purchased a new position in shares of DaVita during the fourth quarter worth about $41,000. Coppell Advisory Solutions LLC grew its holdings in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock worth $45,000 after purchasing an additional 100 shares during the last quarter. Canada Post Corp Registered Pension Plan purchased a new position in shares of DaVita during the fourth quarter worth about $55,000. Finally, Quarry LP purchased a new position in shares of DaVita during the third quarter worth about $60,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.
DaVita Company Profile
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Read More
- Five stocks we like better than DaVita
- What Are Trending Stocks? Trending Stocks Explained
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Basic Materials Stocks Investing
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Investing in Commodities: What Are They? How to Invest in Them
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.